Search

Your search keyword '"FASCIOLA hepatica"' showing total 10,181 results

Search Constraints

Start Over You searched for: Descriptor "FASCIOLA hepatica" Remove constraint Descriptor: "FASCIOLA hepatica"
10,181 results on '"FASCIOLA hepatica"'

Search Results

201. Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica

202. Antigens from the Helminth Fasciola hepatica Exert Antiviral Effects against SARS-CoV-2 In Vitro

203. Substrate Specificity of Cysteine Proteases Beyond the S2 Pocket: Mutagenesis and Molecular Dynamics Investigation of Fasciola hepatica Cathepsins L.

204. Prevalence and gross pathology of liver fluke in macropods cohabiting livestock farms in north eastern NSW, Australia, and diagnosis using cELISA

205. Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola Gigantica that cause the zoonosis Fasciolosis

206. Successful Treatment of Fasciola hepatica with Metronidazole in a Child: A Case Report

207. High relatedness of bioinformatic data and realistic experimental works on the potentials of Fasciola hepatica and F. gigantica cathepsin L1 as a diagnostic and vaccine antigen

208. Prevalence of Fascioliasis in Ruminants of the World — meta-analysis

209. Potential biomonitoring of the environmental contamination using snails as sentinel organism: A case study from the Manzala Lagoon, Egypt

210. Study of the migration of Fasciola hepatica juveniles across the intestinal barrier of the host by quantitative proteomics in an ex vivo model.

211. Gross and histologic description of trematodosis in fetal and neonatal beef calves in North Dakota and Minnesota.

212. Fascioliasis en hígados decomisados de bovinos en el Camal Frigorífico Municipal de Ambato y su relación con la Seguridad Alimentaria.

213. PREVALENCE OF FASCIOLIASIS IN RUMINANTS OF THE WORLD -- META-ANALYSIS.

215. Environmental detection of Fasciola hepatica by loop-mediated isothermal amplification.

216. Identification and Genetic Characterization of Fasciola hepatica Isolated from Cattle in Jeddah, Saudi Arabia Based on Sequence Analysis of Mitochondrial (COI) Gene.

217. Effect of Fasciola Hepatica Invasion on Cow Productivity.

218. Construction of a multiepitope vaccine candidate against Fasciola hepatica: an in silico design using various immunogenic excretory/secretory antigens.

219. Fosfatriclaben: Effective dose determination and comparative efficacy assessment with closantel, triclabendazole+ivermectin, triclabendazole+albendazole in artificially infected cattle.

220. Assessment of accuracy of liver fluke diagnostic tests using the gold standard of total worm counts.

221. Fasciola hepatica : Updates on egg morphology, host range, and distribution.

224. Immunomodulatory Effects of the Somatic Antigens of Fasciola Hepatica and Teladorgasia Circumcincta in Mice Immunized with Sheep Red Blood Cells

225. Study of triclabendazole effects on Fasciola hepatica’s life-supporting organs, spines and suckers responsible for stable position of the parasite in the host

226. Study on the role of age, sex and season on the prevalence of fascioliasis and dicrocoeliasis in animals slaughtered in Tabriz slaughterhouse

227. Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru

228. Accurate and rapid detection of Fasciola hepatica copro‐DNA in sheep using loop‐mediated isothermal amplification (LAMP) technique

229. Human fascioliasis due to Fasciola hepatica in Kurdistan, Iran: A case report

230. Epidemiology of bovine tuberculosis and influence of liver fluke co-infection in Cameroon, Central Africa

231. Environmental detection of Fasciola hepatica by loop-mediated isothermal amplification

232. Epidemiological Survey and Confirmation of Autochthonous Cases of Bovine Fasciolosis in the Serrana Mesoregion of Santa Catarina, Brazil

233. The First Case of Human Hepatic Fasciolosis Presented as Hepatic Pseudotumor Histopathologically Diagnosed in Romania—A Case Report

234. Helminth parasites are associated with reduced survival probability in young red deer.

235. Liver Abscess due to Fasciola hepatica: A Case Report of the North of Iran.

236. Geospatial analysis of the associations between environmental contamination with livestock feces and children with chronic fascioliasis in the Anta province of Cusco, Peru.

237. Fasciolosis—An Increasing Challenge in the Sheep Industry.

238. Stage-specific miRNAs regulate gene expression associated with growth, development and parasite-host interaction during the intra-mammalian migration of the zoonotic helminth parasite Fasciola hepatica.

239. Proteomic Analysis of Extracellular Vesicles From Fasciola hepatica Hatching Eggs and Juveniles in Culture.

240. A Comparative Study of Fasciola Parasite Infection Rates in Local and Imported Sheep in Jeddah, Saudi Arabia.

241. Effect of primary and secondary Fasciola gigantica infection on specific IgG responses, hepatic enzyme levels and weight gain in buffaloes.

242. Molecular characteristics and genetic diversity of Fasciola hepatica from sheep in Xinjiang, China.

243. The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations.

244. Fasciola hepatica Gastrodermal Cells Selectively Release Extracellular Vesicles via a Novel Atypical Secretory Mechanism.

245. Biochemical Evaluation of Antioxidant Enzyme Activities and Lipid Peroxidation Level Associated with Liver Enzymes in Patients with Fascioliasis.

246. Targeting the PI3K/Akt signaling pathway in pancreatic β‐cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes.

247. Molecular Identification of Fasciola spp. Isolated from Domestic Animals Based on DNA Sequencing of the Nuclear Ribosomal ITS1 -ITS2 Markers, Kurdistan Region, Iraq.

248. Spatial visualization of drug uptake and distribution in Fasciola hepatica using high-resolution AP-SMALDI mass spectrometry imaging.

249. Molecular Characteristics and Potent Immunomodulatory Activity of Fasciola hepatica Cystatin.

250. Rendimiento diagnóstico de la prueba rápida fasciorap basada en la técnica de inmunocromatografía o flujo lateral para la detección de anticuerpos en pacientes con Fasciolosis humana.

Catalog

Books, media, physical & digital resources